Latest News

  • INVESTMENT

    6 Apr 2026

    RNA Gets a $2.4B Promotion at Eli Lilly

  • PARTNERSHIPS

    31 Mar 2026

    RNA Meets Cell Therapy, and Texas Is Holding the Handshake

  • REGULATORY

    26 Mar 2026

    No Trial? No Problem. FDA Rewrites the RNA Rules

  • INVESTMENT

    23 Mar 2026

    New Funding Backs Precision in mRNA Medicine

Fatty Bubbles and the $2.25 Billion Peace

Red Moderna logo signage mounted on building exterior above entrance

PARTNERSHIPS

17 Mar 2026

Moderna settles landmark LNP patent dispute for up to $2.25B, securing a royalty-free delivery license for its infectious disease vaccine programs

Labelled mRNA vaccine vial with syringe, capsules and stethoscope on medical form

MARKET TRENDS

19 Feb 2026

mRNA Groups Press Ahead in Cancer Push

Personalised oncology programmes advance as regulators engage and payers scrutinise costs

Researcher analyzing mRNA samples in biotech lab

TECHNOLOGY

18 Feb 2026

How the Cloud Powers the Next mRNA Breakthrough

Biotech firms are using cloud platforms to accelerate mRNA research while managing compliance, security, and rising costs

Medical syringe containing mRNA vaccine held by healthcare worker in gloves

INSIGHTS

16 Feb 2026

Can Europe Win the mRNA Cancer Race?

A €6.9 million EU grant backs eTheRNA’s cancer vaccines and signals Europe’s long-term bet on mRNA oncology

Gloved hand preparing vaccine dose from vial

REGULATORY

12 Feb 2026

FDA Refusal-to-File Resets mRNA Flu Strategy

Agency’s decision signals tougher trial standards for seasonal vaccine approvals as pandemic-era flexibility recedes  

Laboratory technician working on RNA biomanufacturing equipment

INNOVATION

11 Feb 2026

Britain’s Bet On Better RNA Factories

As saRNA advances in 2026, CPI’s RNA infrastructure is reinforcing the UK’s role in Europe’s evolving vaccine manufacturing landscape

Syringe labeled Moderna mRNA-3927 with Recordati logo in background

PARTNERSHIPS

10 Feb 2026

Moderna and Recordati Bet on mRNA Beyond Vaccines

Moderna and Recordati partner on an mRNA therapy for propionic acidemia, combining resources to accelerate development

SUBSCRIBE FOR UPDATES

By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.